Spots Global Cancer Trial Database for Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer

Official Title: Comparison of the Urinary and Vaginal Auto-takings for the Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer.

Study ID: NCT02137694

Conditions

Research Human Papillomavirus ( HPV) by Vaginal Auto-takings ( APV) and Urinary Test

Interventions

vaginal auto-takings and urinary test

Study Description

Brief Summary: Auto-takings by APU and vaginal APV during the consultations for FCU in the department of gynecology-obstetrics (Group 1) according to an instructions for use proposed to the inclusive women, with consent; the same proposal, APU and APV, is made for other consultations requiring a screening on the CHRU (Group 2: dermatology, endocrinology, ambulatory surgery, inner medicine, pneumology, oncology). Auto-takings transmitted in the laboratory of the CHRU of Brest for test HPV by quantitative real-time PCR. Results transmitted to the women and to the doctors of consultation. In case of positive test (15 %), the patients are directed to a gynecologist. Confrontation with the cytological data when available (Group 1) .

Detailed Description: